Catalysis research at HZB gets new facility

The facility consists of a total of eight chemical reactors in which catalytic systems can be tested.

The facility consists of a total of eight chemical reactors in which catalytic systems can be tested. © D. Amkreutz/HZB

Each block of the chemical reactors is roughly 3 to 4 meters wide and a bit under 2 meters high. The facility consists of two blocks and weighs 3 tons in total.

Each block of the chemical reactors is roughly 3 to 4 meters wide and a bit under 2 meters high. The facility consists of two blocks and weighs 3 tons in total. © R. Schlatmann/HZB

As part of the CatLab project, HZB has acquired a unique facility for measuring the catalytic performance of thin-film catalysts. Built by ILS in Adlershof, it has now been delivered. The facility consists of a total of eight chemical reactors in which catalytic systems can be tested. At over €2.5 million, this is the largest single investment in the CatLab project.

‘The reactors enable thin-film and powder samples to be examined continuously or in batches under adjustable conditions, from room temperature to 780 °C, at pressures up to 50 bar and different flow rates and residence times. This allows us to investigate a wide range of chemical reactions that are important for the energy transition,’ says project manager Dr. Ing. Albert Gili from HZB.

Examples of such reactions include the conversion of carbon dioxide to methanol, the dry reforming of methane, and the Fischer-Tropsch synthesis, which can be used to produce synthetic fuels. The facility enables the screening of catalyst candidates, kinetic investigations, and studies on the long-term stability of catalysts. The latter is a decisive factor for the industrial implementation of any catalytic reaction. ‘The facility will be a cornerstone for the further development of thin-film catalyst production, not only for CatLab, but also for our in-house research and other important projects such as CARE-O-SENE, Greenquest and several new ones in the pipeline,’ says Prof. Dr. Rutger Schlatmann, CatLab overall project lead at HZB.

red.

  • Copy link

You might also be interested in

  • Berlin Battery Lab: BAM, HZB and HU are conducting joint research on sodium batteries
    News
    19.03.2026
    Berlin Battery Lab: BAM, HZB and HU are conducting joint research on sodium batteries
    The Federal Institute for Materials Research and Testing (BAM), the Helmholtz Zentrum Berlin (HZB) and Humboldt-Universität zu Berlin (HU) today officially inaugurated the Berlin Battery Lab (BBL). At this new research platform, BAM, HZB and HU jointly develop and test resource-efficient battery technologies with a focus on sodium-based systems. Together, they develop new materials, investigate innovative cell chemistries, and produce battery prototypes. The research infrastructure of the Berlin Battery Lab is also open to external partners from science and industry and is designed to accelerate the transfer from research to application.
  • Humboldt-Fellow at HZB Institute for Solar Fuels: Kayode Adesina Adegoke
    News
    18.03.2026
    Humboldt-Fellow at HZB Institute for Solar Fuels: Kayode Adesina Adegoke
    Kayode Adesina Adegoke is a renowned chemist, affiliated with LAUTECH SDG 11 (Sustainable Cities and Communities Research Group), Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, Ogbomoso, Nigeria. He is collaborating with Matthew Mayer to investigate the degradation of electrocatalysts during electrochemical CO₂ reduction. The Alexander von Humboldt Fellowship enables him to stay at Helmholtz Zentrum Berlin up to 24 months.
  • Protein crystallography at BESSY II: faster, better and more and more automatic
    Interview
    04.03.2026
    Protein crystallography at BESSY II: faster, better and more and more automatic
    Many diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with  Manfred Weiss, head of the research group for macromolecular crystallography.